| 1 |
Rodríguez-giraldo M, González-reyes RE, Ramírez-guerrero S, Bonilla-trilleras CE, Guardo-maya S, Nava-mesa MO. Astrocytes as a Therapeutic Target in Alzheimer’s Disease–Comprehensive Review and Recent Developments. IJMS 2022;23:13630. [DOI: 10.3390/ijms232113630] [Reference Citation Analysis]
|
| 2 |
Valenza M, Scuderi C. How useful are biomarkers for the diagnosis of Alzheimer's disease and especially for its therapy? Neural Regen Res 2022;17:2205-7. [PMID: 35259832 DOI: 10.4103/1673-5374.335791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Valenza M, Facchinetti R, Steardo L, Scuderi C. Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications. Biomolecules 2022;12:1191. [DOI: 10.3390/biom12091191] [Reference Citation Analysis]
|
| 4 |
Steardo L Jr, Steardo L, Scuderi C. Astrocytes and the Psychiatric Sequelae of COVID-19: What We Learned from the Pandemic. Neurochem Res 2022. [PMID: 35922744 DOI: 10.1007/s11064-022-03709-7] [Reference Citation Analysis]
|
| 5 |
Facchinetti R, Valenza M, Gomiero C, Mancini GF, Steardo L, Campolongo P, Scuderi C. Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-α in an In Vitro Model of Alzheimer’s Disease. Biomedicines 2022;10:1236. [DOI: 10.3390/biomedicines10061236] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 6 |
Zhou X, Venigalla M, Raju R, Münch G. Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer's disease. J Neural Transm (Vienna) 2022. [PMID: 35294663 DOI: 10.1007/s00702-022-02480-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Vandenbark AA, Offner H, Matejuk S, Matejuk A. Microglia and astrocyte involvement in neurodegeneration and brain cancer. J Neuroinflammation 2021;18:298. [PMID: 34949203 DOI: 10.1186/s12974-021-02355-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Merlo S, Spampinato SF, Lim D. Molecular Aspects of Cellular Dysfunction in Alzheimer's Disease: The Need for a Holistic View of the Early Pathogenesis. Biomolecules 2021;11:1807. [PMID: 34944450 DOI: 10.3390/biom11121807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Staurenghi E, Giannelli S, Testa G, Sottero B, Leonarduzzi G, Gamba P. Cholesterol Dysmetabolism in Alzheimer's Disease: A Starring Role for Astrocytes? Antioxidants (Basel) 2021;10:1890. [PMID: 34943002 DOI: 10.3390/antiox10121890] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 10 |
Scuderi C, Golini L. Successful and Unsuccessful Brain Aging in Pets: Pathophysiological Mechanisms behind Clinical Signs and Potential Benefits from Palmitoylethanolamide Nutritional Intervention. Animals (Basel) 2021;11:2584. [PMID: 34573549 DOI: 10.3390/ani11092584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
